Precision Medicine in Gastrointestinal Neoplasms
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 51
Special Issue Editors
Interests: peritoneal oncology; digestive cancers
2. Liquid Biopsy and Cancer Interception Group, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016 Granada, Spain
Interests: liquid biopsy; circulating tumor cells (CTCs); platelets educated tumor (PETs); extracellular vesicles (EVs); circulating tumor nucleic acids (ctNA); cancer interception (CI)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Precision medicine in gastrointestinal malignancies represents an innovative and highly specialized approach to cancer treatment. This paradigm focuses on personalizing treatment based on the specific genetic and molecular characteristics of each patient's tumor, as well as other individual factors.
The focus of this Special Issue is on, but not limited to, the following:
- Tumor genomics or DNA sequencing
- Biomarkers: predictive or prognostic
- Targeted therapies
- Immunotherapy.
Moreover, some challenges we are currently facing that should be clarified in the near future include the following:
- Accessibility and Cost: Genetic testing and targeted therapies can be expensive and are not always covered by insurance.
- Continuous Research: Need for clinical studies that validate new therapies and combinations.
- Liquid Biopsies: Development of noninvasive methods for monitoring tumor evolution and response to treatment.
In summary, precision medicine in gastrointestinal malignancies promises to significantly improve treatment outcomes by tailoring interventions to each patient's unique characteristics, thereby reducing side effects and increasing treatment efficacy. This Special Issue, entitled “Precision Medicine in Gastrointestinal Neoplasms”, is a great opportunity for teams working on these topics to present their studies, their experiences, and their results. It is undoubted that this Special Issue will contribute to generating a greater degree of knowledge about this exciting topic.
Dr. Juan Torres-Melero
Dr. María Jose Serrano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- digestive cancers
- molecular biology
- gastrointestinal cancers
- gynecological cancers
